
    
      This study will evaluate the feasibility of using [18F]ISO-1 PET/CT to image sigma-2 receptor
      binding in primary breast tumors and continue to evaluate the safety of the tracer in this
      patient population. [18F]ISO-1 uptake measures will be correlated with qualitative
      immunohistochemical staining for cell proliferation (Ki67). This is an observational study in
      that [18F]ISO-1 PET/CT will not be used to direct treatment decisions.
    
  